Target-directed cancer: protein-ligand interactions
Drug Target Review
NOVEMBER 1, 2023
For example, in the screening stage of a project we are trying to find initial starting points for optimisation by our medicinal and computational chemistry colleagues. Capivasertib originated from a collaboration between my former company Astex Pharmaceuticals and the ICR and was further developed by AstraZeneca.
96 
Let's personalize your content